PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 20104189-6 2010 RESULTS: The blood pressure response to Ang II was blocked by more than 90% with irbesartan alone or in association with HCTZ and with olmesartan/HCTZ and by nearly 60% with valsartan/HCTZ and losartan/HCTZ (P < 0.05). olmesartan 135-145 angiogenin Homo sapiens 40-43 20104189-8 2010 Irbesartan +/- HCTZ and olmesartan/HCTZ blocked the renal hemodynamic response to Ang II nearly completely, whereas valsartan/HCTZ and losartan/HCTZ only blunted this effect by 34 and 45%, respectively. olmesartan 24-34 angiogenin Homo sapiens 82-85 19804316-5 2008 Olmesartan has demonstrated its dose-dependent inhibitory effect on Ang I-induced blood pressure responses between 10 and 80 mg in Phase II studies. olmesartan 0-10 angiogenin Homo sapiens 68-71 29115506-6 2018 The results of the present study ndicated that Ang II upregulated MCP-1 expression in osteoblasts, which was mitigated by agonists of the AT1R, including olmesartan, a ROS scavenger N-acetylcysteine (NAC), ammonium pyrrolidinethiocarbamate (PDTC) and nuclear factor (NF)-kappaB, but not by the Ang II type 2 receptor antagonist, PD123319. olmesartan 154-164 angiogenin Homo sapiens 47-50